NeoStem Receives Approval for Stem Cell Treatment
NeoStem (NBS) announced its arthroscopic orthopedic treatment, which uses autologous adult stem cells, was approved by Weihai Municipal Price Bureau at Wendeng Orthopedic Hospital. At the same time, reimbursement for the procedure was approved by Weihai Municipal Labor Bureau Medical Insurance Office. Patients are eligible to receive reimbursement for up to 80% of the procedure’s cost.
The stem cell procedure was developed by Regenerative Sciences Inc. NeoStem holds a license to the technology in Asia, and it is signing up hospitals that will offer the procedure. Wendeng Hospital is the first to do so.
Weihai is a prefecture-level city in China’s most northeast province, Shandong.
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.
Get Blog Updates by Email